Clinical Trial

The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this phase 1 study is to evaluate the food effect of 100 mg Hezkue Turbo® (ASP-001.1, sildenafil) under fed versus 100 mg of Hezkue Turbo® (ASP-001.1, sildenafil) under fasted conditions in healthy adult male subjects
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-07; most recent amendment 2025-11-17.
Status change: Not Yet Recruiting → Recruiting 2025-05-20
Trial Details
NCT Number NCT06872866
Lead Sponsor Aspargo Labs, Inc
Conditions Erectile Dysfunction
Enrollment 12 participants
Start Date 2025-04-15
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-11-19